{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:24:55Z","timestamp":1750332295812},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1007\/s11892-002-0070-x","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T08:19:22Z","timestamp":1188375562000},"page":"116-124","source":"Crossref","is-referenced-by-count":8,"title":["HIV-associated lipodystrophy: Description, pathogenesis, and molecular pathways"],"prefix":"10.1007","volume":"2","author":[{"given":"Patrick W. G.","family":"Mallon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella","year":"1998","unstructured":"Palella FJ, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853\u2013860.","journal-title":"N Engl J Med"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51-F58.","journal-title":"AIDS"},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","volume":"351","author":"KD Miller","year":"1998","unstructured":"Miller KD, Jones E, Jack A, et al.: Visceral abdominal-fat accumulation associated with the use of indinavir. Lancet 1998, 351:871\u2013875.","journal-title":"Lancet"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","volume":"108","author":"A Garg","year":"2000","unstructured":"Garg A: Lipodystrophies. Am J Med 2000, 108:143\u2013152.","journal-title":"Am J Med"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","volume":"32","author":"C Hadigan","year":"2001","unstructured":"Hadigan C, Meigs J, Corcoran C, et al.: Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001, 32:130\u2013139.","journal-title":"Clin Infect Dis"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","volume":"31","author":"R Thiebaut","year":"2000","unstructured":"Thiebaut R, Daucourt V, Mercie P, et al.: Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Clin Infect Dis 2000, 31:1482\u20131487.","journal-title":"Clin Infect Dis"},{"key":"70_CR7","unstructured":"Miller JE, Emery S, French M, et al.: The Australian prevalence survey of lipodystrophy syndrome. In Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, January, 2000 (abstract 201)."},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC, et al.: Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001, 15:1389\u20131398.","journal-title":"AIDS"},{"issue":"(suppl 4)","key":"70_CR9","first-page":"S54","volume":"14","author":"M Galli","year":"2000","unstructured":"Galli M, Veglia F, Angarano G, et al.: Metabolic and morphological alterations under antiretroviral therapy: preliminary results of lipodystrophy Italian Multicentre Study (LIMS). Abstracts of the Fifth International Congress on Drug Therapy in HIV Infection; October 22-26, 2000; Glasgow, United Kingdom. AIDS 2000, 14(ppl 4):S54. Abstract P133.","journal-title":"Abstracts of the Fifth International Congress on Drug Therapy in HIV Infection"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A, Miller J, Law M, Cooper DA: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000, 14:F25-F32.","journal-title":"AIDS"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","volume":"357","author":"E Martinez","year":"2001","unstructured":"Martinez E, Mocroft A, Garcia-Viejo MA, et al.: Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001, 357:592\u2013598.","journal-title":"Lancet"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200107010-00004","volume":"27","author":"JR Bogner","year":"2001","unstructured":"Bogner JR, Vielhauer V, Beckmann RA, et al.: Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr 2001, 27:237\u2013244.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1310\/BRE5-448N-WUPU-JWVL","volume":"2","author":"F Boufassa","year":"2001","unstructured":"Boufassa F, Dulioust A, Lascaux AS, et al.: Lipodytrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response. HIV Clin Trials 2001, 2:339- 345.","journal-title":"HIV Clin Trials"},{"key":"70_CR14","unstructured":"Boubaker K, Sudre P, Flepp M, et al.: Hyperlactatemia and antiretroviral therapy in the Swiss HIV Cohort Study. In Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, January, 2000 (abstract 57)."},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","volume":"15","author":"M Valk van der","year":"2001","unstructured":"van der Valk M, Gisolf EH, Reiss P, et al.: Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included in the treatment of HIV-1 infection. AIDS 2001, 15:847\u2013855.","journal-title":"AIDS"},{"key":"70_CR16","unstructured":"Gan SK, Samaras K, Thompson C, et al.: Correlations between intramyocellular lipid, visceral fat and insulin sensitivity: a study of HIV positive subjects with and without peripheral lipodystrophy. Abstracts from the American Diabetes Association 61st Scientific Meeting, Philadelphia, PA, June 22\u201326. Diabetes 2001, 50(suppl 2):A315."},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","volume":"409","author":"ED Abel","year":"2001","unstructured":"Abel ED, Peroni O, Kim JK, et al.: Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409:729\u2013733. Raises the possibility of communication between adipose tissue, liver, and muscle with respect to insulin sensitivity. Although written with respect to the pathogenesis of type 2 diabetes, this model could be applied to HIVLD.","journal-title":"Nature"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2337\/diacare.23.10.1545","volume":"23","author":"A Garg","year":"2000","unstructured":"Garg A, Parsons D, Stray-Gundersen J, Bertocci LA: Skeletal muscle morphology and exercise response in congenital generalised lipodystrophy. Diabetes Care 2000, 23:1545\u20131550.","journal-title":"Diabetes Care"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","volume":"275","author":"P Dowell","year":"2000","unstructured":"Dowell P, Flexner C, Kwiterovich P, Lane MD: Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 2000, 275:41325\u201341332. This is an important work performed in vitro on adipocytes defining important effects of PIs on adipocytes independent of HIV infection and other drug classes.","journal-title":"J Biol Chem"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","volume":"12","author":"I Shimomura","year":"1998","unstructured":"Shimomura I, Hammer RE, Richardson JA, et al.: Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SPEBP-1 in adipose tissue: model for congenital generalised lipodystrophy. Gen Dev 1998, 12:3182\u20133194.","journal-title":"Gen Dev"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","volume":"50","author":"M Caron","year":"2001","unstructured":"Caron M, Auclair M, Vigouroux C, et al.: The HIV protease inhibitor indinavir impairs sterol regulatory elementbinding protein-1 intranuclear localisation, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001, 50:1378\u20131388. Provides important information as to effect of PIs on protein function in adipocytes. PIs not only affect expression of adipocyte-specific proteins, but also affect their ability to function.","journal-title":"Diabetes"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.147.5.913","volume":"147","author":"T Sullivan","year":"1999","unstructured":"Sullivan T, Escalante-Alcade D, Bhatt H, et al.: Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913\u2013919.","journal-title":"J Cell Biol"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/00002030-200011100-00007","volume":"14","author":"AT Nguyen","year":"2000","unstructured":"Nguyen AT, Gagnon A, Angel JB, Sorisky A: Ritonavir increases the level of active ADD-1\/SREBP-1 protein during adipogenesis. AIDS 2000, 14:2467\u20132473.","journal-title":"AIDS"},{"key":"70_CR24","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","volume":"13","author":"P Domingo","year":"1999","unstructured":"Domingo P, Matias-Guiu X, Pujol RP, et al.: Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 1999, 13:2261\u20132267.","journal-title":"AIDS"},{"key":"70_CR25","first-page":"1205","volume":"151","author":"Z Dong","year":"1997","unstructured":"Dong Z, Saikumar P, Weinberg M, Venkatachalam MA: Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Am J Pathol 1997, 151:1205\u20131213.","journal-title":"Am J Pathol"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","volume":"25","author":"DC Mynarcik","year":"2000","unstructured":"Mynarcik DC, McNurlan MA, Steigbigel RT, et al.: Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 2000, 25:312\u2013321.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","volume":"95","author":"E Ledru","year":"2000","unstructured":"Ledru E, Christeff N, Patey O, et al.: Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome. Blood 2000, 95:3191\u20133198.","journal-title":"Blood"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1093\/jn\/129.1.243S","volume":"129","author":"MJ Tisdale","year":"1999","unstructured":"Tisdale MJ: Wasting in cancer. J Nutr 1999, 129(1S suppl):243S-246S.","journal-title":"J Nutr"},{"issue":"suppl 2","key":"70_CR29","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","volume":"30","author":"A Carr","year":"2000","unstructured":"Carr A: HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000, 30(suppl 2):S135-S142.","journal-title":"Clin Infect Dis"},{"key":"70_CR30","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diab.46.12.1939","volume":"46","author":"JB Prins","year":"1997","unstructured":"Prins JB, Niesler CU, Winterford CM, et al.: Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 1997, 46:1939\u20131944.","journal-title":"Diabetes"},{"key":"70_CR31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","volume":"12","author":"K Brinkman","year":"1998","unstructured":"Brinkman K, ter Hofstede HJM, Burger DM, et al.: Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998, 12:1735\u20131744.","journal-title":"AIDS"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","volume":"15","author":"C Shikuma","year":"2001","unstructured":"Shikuma C, Hu N, Milne C, et al.: Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV infected individuals with peripheral lipoatrophy. AIDS 2001, 15:1801- 1809.","journal-title":"AIDS"},{"key":"70_CR33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","volume":"133","author":"E Arioglu","year":"2000","unstructured":"Arioglu E, Duncan-Morin J, Sebring N, et al.: Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 2000, 133:263\u2013274.","journal-title":"Ann Intern Med"},{"key":"70_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-134-1-200101020-00014","volume":"134","author":"AA Parulkar","year":"2001","unstructured":"Parulkar AA, Pendergrass ML, Granda-Ayala R, et al.: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med 2001, 134:61\u201371.","journal-title":"Ann Intern Med"},{"key":"70_CR35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","volume":"105","author":"O Gavrilova","year":"2000","unstructured":"Gavrilova O, Marcus-Samuels B, Graham D, et al.: Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000, 105;271\u2013278.","journal-title":"J Clin Invest"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, et al.: Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999, 353:2093\u20132099.","journal-title":"Lancet"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","volume":"351","author":"KD Miller","year":"1998","unstructured":"Miller KD, Jones E, Jack A, et al.: Visceral abdominal-fat accumulation associated with the use of indinavir. Lancet 1998, 351:871\u2013875.","journal-title":"Lancet"},{"key":"70_CR38","doi-asserted-by":"crossref","first-page":"354S","DOI":"10.1093\/jn\/131.2.354S","volume":"131","author":"SE Kahn","year":"2001","unstructured":"Kahn SE, Prigeon RL, Schwartz RS, et al.: Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001, 131:354S-360S.","journal-title":"J Nutr"},{"key":"70_CR39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200105250-00005","volume":"15","author":"JS Huang","year":"2001","unstructured":"Huang JS, Rietschel P, Hadigan CM, et al.: Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS 2001, 15:975\u2013982.","journal-title":"AIDS"},{"key":"70_CR40","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","volume":"13","author":"C Wanke","year":"1999","unstructured":"Wanke C, Gerrior J, Kantaros J, et al.: Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS 1999, 13:2099\u20132103.","journal-title":"AIDS"},{"key":"70_CR41","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","volume":"15","author":"A Carr","year":"2001","unstructured":"Carr A, Hudson J, Chuah J, et al.: HIV protease inhibitor substitution in patients with lipodystrophy: a randomised controlled, open-label, multicentre study. AIDS 2001, 15:1811\u20131822.","journal-title":"AIDS"},{"key":"70_CR42","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","volume":"275","author":"H Murata","year":"2000","unstructured":"Murata H, Hruz PW, Mueckler M: The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 2000, 275:20251\u201320254.","journal-title":"J Biol Chem"},{"key":"70_CR43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35055643","volume":"409","author":"MJ Birnbaum","year":"2001","unstructured":"Birnbaum MJ: Dialogue between muscle and fat. Nature 2001, 409:672\u2013673.","journal-title":"Nature"},{"key":"70_CR44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1530\/eje.0.1420114","volume":"142","author":"J Berg","year":"2000","unstructured":"Berg J: Leptin is a potent anti-diabetic in mice with lipodystrophy and insulin resistance. Eur J Endocrinol 2000, 142:114\u2013116.","journal-title":"Eur J Endocrinol"},{"key":"70_CR45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","volume":"284","author":"C Hadigan","year":"2000","unstructured":"Hadigan C, Corcoran C, Basgoz N, et al.: Metformin in the treatment of HIV lipodystrophy syndrome. A randomised controlled trial. JAMA 2000, 284:472\u2013477.","journal-title":"JAMA"},{"key":"70_CR46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00002030-199905280-00023","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Touraine J-L: Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy. AIDS 1999, 13:1000\u20131002.","journal-title":"AIDS"},{"key":"70_CR47","first-page":"45","volume":"6","author":"PW Mallon","year":"2001","unstructured":"Mallon PW: Switch therapy studies. J HIV Ther 2001, 6:45\u201348.","journal-title":"J HIV Ther"},{"key":"70_CR48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004330050123","volume":"199","author":"RK Walli","year":"2000","unstructured":"Walli RK, Michl GM, Muhlbayer D, et al.: Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. Res Exp Med (Berl) 2000, 199:253\u2013262.","journal-title":"Res Exp Med (Berl)"},{"key":"70_CR49","unstructured":"Parker RA, Meyers DS, Andrews BA, et al.: Effects of nucleoside reverse transcriptase inhibitors and HIV protease inhibitors on adipogenesis and adipocyte metabolism. In Abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada, September, 2000;04:4."},{"key":"70_CR50","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","volume":"20","author":"JM Lenhard","year":"2000","unstructured":"Lenhard JM, Croom DK, Weiel JE, Winegar DA: HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arterioscler Thromb Vasc Biol 2000, 20:2625\u20132629.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"70_CR51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Barak Y, Nagy L, et al.: PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001, 7:48\u201352. Details the importance of PPARg not only on adipocyte function, but also on macrophage function. This contributes to our understanding of the possible effects of PIs on macrophages with respect to accelerated atherosclerosis.","journal-title":"Nat Med"},{"key":"70_CR52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","volume":"7","author":"G Chinetti","year":"2001","unstructured":"Chinetti G, Lestavel S, Bocher V, et al.: PPAR-alpha and PPARgamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001, 7:53\u201358.","journal-title":"Nat Med"},{"key":"70_CR53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/83328","volume":"7","author":"KJ Moore","year":"2001","unstructured":"Moore KJ, Rosen ED, Fitzgerald ML, et al.: The role of PPARgamma in macrophage differentiation and cholesterol uptake. Nat Med 2001, 7:41\u201347.","journal-title":"Nat Med"},{"key":"70_CR54","unstructured":"Smart EJ, Matveev S, Kincer J, Greenberg RN: Protease inhibitors up-regulate SR-BI and HDL-dependent cholesterol uptake in human macrophages: a mechanism that may enhance foam cell formation. In 8th Conference on Retrovirus and Opportunistic Infections, Chicago, IL, February 4\u20138, 2001;662:243."},{"key":"70_CR55","unstructured":"Miller J, Carr A, Brown D, Cooper DA: A randomised, doubleblind study of gemfibrozil (GF) for the treatment of protease inhibitor-associated hypertriglyceridaemia. In 8th Conference on Retrovirus and Opportunistic Infections, Chicago, IL, February 4\u20138, 2001;540:205."},{"key":"70_CR56","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/00002030-200007280-00025","volume":"14","author":"F Baldini","year":"2000","unstructured":"Baldini F, Di Giambenedetto S, Cingolani A, et al.: Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study. AIDS 2000, 14:1660\u20131662.","journal-title":"AIDS"},{"key":"70_CR57","unstructured":"Carr A, Hudson J, Law M, Cooper DA: A randomised, multicentre study of protease inhibitor substitution in aviraemic patients with lipodystrophy (LD): 48 week data. In Abstracts of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada, September, 2000;P84:73."},{"key":"70_CR58","unstructured":"Walli R, Huster K, Bogner JR, et al.: Switching from PI to ABC improves insulin sensitivity and fasting lipids\u201412 month follow-up. In 8th Conference on Retrovirus and Opportunistic Infections, Chicago, IL, February 4\u20138, 2001;672:246."},{"key":"70_CR59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0953-6205(00)00103-5","volume":"11","author":"P Mercie","year":"2000","unstructured":"Mercie P, Tchamgoue S, Thiebaut R, et al.: Atherogenic lipid profile in HIV-infected patients with lipodystrophy syndrome. Eur J Int Med 2000, 11:257\u2013263.","journal-title":"Eur J Int Med"},{"key":"70_CR60","unstructured":"Mary-Krause M, Cotte L, Partisani M, et al.: Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV-infected men. In 8th Conference on Retrovirus and Opportunistic Infections, Chicago, IL, February 4\u20138, 2001;657:241."},{"key":"70_CR61","unstructured":"Klein D, Hurley L, Sorel M, Sidney S: Do protease inhibitors increase the risk for coronary heart disease among HIV positive patients? Follow-up through June 2000. In 8th Conference on Retrovirus and Opportunistic Infections, Chicago, IL, February 4\u20138, 2001;655:241."},{"key":"70_CR62","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.STR.31.10.2426","volume":"31","author":"D Baldassarre","year":"2000","unstructured":"Baldassarre D, Amato M, Bondioli A, et al.: Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 2000, 31:2426\u20132430.","journal-title":"Stroke"},{"key":"70_CR63","unstructured":"Sosman JM, Klein MA, Bellehumeur SE, et al.: Endothelial dysfunction is associated with the use of human immunodeficiency virus type 1 protease inhibitors. In 7th Conference on Retrovirus and Opportunistic Infections, San Francisco, CA, January 30\u2013February 2, 2000;29:80."}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-002-0070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-002-0070-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-002-0070-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T05:44:53Z","timestamp":1587879893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-002-0070-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11892-002-0070-x","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}